News

The American Headache Society’s Methodology, Design & Statistical Issues Section is a group of headache investigators dedicated to developing and disseminating research methods to conduct rigorous headache science.

This fall, the American Headache Society is proud to offer two programs dedicated to developing leaders within the Society and field of Headache Medicine. These professional development programs were designed to support AHS members at different stages in their careers.

The mission of the New Investigators and Trainees (NIT) Section of the American Headache Society is fourfold: to recruit and longitudinally support junior members as they embark into the exciting field of headache medicine, to create a forum for collaboration and mentorship/sponsorship...

For Pride Month, we would like highlight our LGBTQIA+ Health Special Interest Section, which is composed of a diverse group of professionals dedicated to advancing the clinical care for sexual and gender minorities who suffer from headache disorders. We are working on improving access to care and advocating for patients who identify as LGBTQIA+.

The AHS Diversity, Equity, and Inclusion (DEI) Task Force is an initiative commissioned in 2020 by then-President Dr. Peter Goadsby and the AHS Board of Directors. Our mission is to infuse DEI to enhance the leadership and membership of the AHS to provide equitable care and improve the lives of people with headache disorders.

The American Headache Society’s Behavioral Section is a group of clinicians and researchers committed to improving symptoms and quality of life among individuals with headache disorders through behavioral intervention. In addition to involvement in research supporting the efficacy of these interventions, we aim to improve behavioral health access through educating providers and patients.

The American Headache Society (AHS) and National Institute of Neurological Disorders and Stroke (NINDS) request your input during the Headache Research Priorities Public Comment Period.

The Underserved Populations in Headache Medicine Section is always striving to find ways to optimize management and treatment of headache disorders in our underserved communities.

The Women’s Health Special Interest Section is a diverse group of professionals that aim to advance women’s health in headache medicine

Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine with or without aura in adults.

The Pharmacology and Therapeutics Special Interest Section was started to meet an unmet need of in-depth education and understanding in the ever-expanding pharmacotherapy advances in headache medicine.

Headache: The Journal of Head and Face Pain is recruiting a new class of trainees to join its Editorial Board through the Assistant Editor Team Program.

As the Overall Special Interest Section (SIS) Chair, Chair of the Post-traumatic Headache Section, and member of the Education, Leadership Development, and Scientific Program Committees, it is an honor to serve the Society.

I never intended to become a migraine specialist, let alone specialising in hormonal aspects of migraine, but curiosity about a condition that so little was known about, yet resulted in such significant disability, became an obsession as I wanted to find answers to the problems.